Comparative Efficacy of 20% Benzocaine Versus TAC Alternate Gel

NCT ID: NCT00846690

Last Updated: 2009-02-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

PHASE4

Total Enrollment

20 participants

Study Classification

INTERVENTIONAL

Study Start Date

2009-01-31

Study Completion Date

2009-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The project is a study comparing the effectiveness of two topical anesthetics for control of pain associated with dental needle insertion in the palatal mucosa. A standard dental topical anesthetic (20% benzocaine) will serve as an "active" control and will be compared to a combination topical anesthetic, consisting of 20% lidocaine, 4% tetracaine and 2% phenylephrine (TAC Alternate Gel, Compounding Arts Pharmacy, Lafayette, LA).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Dental Pain Postoperative Pain

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Caregivers

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Benzocaine

serves as "active" control

Group Type ACTIVE_COMPARATOR

benzocaine

Intervention Type DRUG

20% benzocaine., topical placement onto site, minimal amount, for 1 minute

TAC

serves as comparator

Group Type EXPERIMENTAL

TAC alternate gel

Intervention Type DRUG

use 1 pump, place topically onto site, leave for 1-3 minutes

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

benzocaine

20% benzocaine., topical placement onto site, minimal amount, for 1 minute

Intervention Type DRUG

TAC alternate gel

use 1 pump, place topically onto site, leave for 1-3 minutes

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Hurricaine 20% TAC alternate gel

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Volunteers 18 years or older
2. Ability to consent to participate in the research
3. Ability to communicate a VAS score
4. Generally healthy, ASA I and ASA II
5. No known drug allergies
6. Ability to tolerate pulse oximeter and blood pressure cuff without psychological, or physiological consequence

Exclusion Criteria

1. Allergy or other contraindications to the topical anesthetics
2. Inability to consent to participation in the study
3. Use of analgesics prior to the procedure
4. Vulnerable populations
Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

The University of Texas Health Science Center, Houston

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

University of Texas Health Science Center Houston

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Femme L Ambrosio, DDS

Role: PRINCIPAL_INVESTIGATOR

UT Health Science Center Houston

Arthur H Jeske, DDS, PhD

Role: STUDY_CHAIR

UT Health Science Center Houston

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

UT Pediatric Dentistry Clinic Houston Medical Center

6655 Travis Suite 460, Texas, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Femme L Ambrosio, DDS

Role: CONTACT

858 603-6345

Arthur H Jeske, DDS, PhD

Role: CONTACT

713 500 4506

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Femme L Ambrosio, DDS

Role: primary

858-603-6345

Arthur H Jeske, DDS PhD

Role: backup

7135004506

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

HSC-DB-08-0484

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.